Bibliographic Details
| Title: |
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial |
| Authors: |
Haas, Naomi B, Manola, Judith, Uzzo, Robert G, Flaherty, Keith T, Wood, Christopher G, Kane, Christopher, Jewett, Michael, Dutcher, Janice P, Atkins, Michael B, Pins, Michael, Wilding, George, Cella, David, Wagner, Lynne, Matin, Surena, Kuzel, Timothy M, Sexton, Wade J, Wong, Yu-Ning, Choueiri, Toni K, Pili, Roberto, Puzanov, Igor, Kohli, Manish, Stadler, Walter, Carducci, Michael, Coomes, Robert, DiPaola, Robert S |
| Source: |
In The Lancet 14-20 May 2016 387(10032):2008-2016 |
| Database: |
ScienceDirect |
